We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

A kind of magic

10 Nov 2021 By Dasha Afanasieva

A study showed magic-mushroom drug psilocybin can treat depression. But 5% of patients suffered side-effects like self-harm, hammering shares in $1.5 bln Compass Pathways, which ran the trial. Beating this will take time, money and expertise. Whoever does, has a path to profit.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)